233 related articles for article (PubMed ID: 20852028)
21. Circulatory changes of the novel adipokine adipolin/CTRP12 in response to metformin treatment and an oral glucose challenge in humans.
Tan BK; Chen J; Hu J; Amar O; Mattu HS; Ramanjaneya M; Patel V; Lehnert H; Randeva HS
Clin Endocrinol (Oxf); 2014 Dec; 81(6):841-6. PubMed ID: 24612181
[TBL] [Abstract][Full Text] [Related]
22. Relationship among plasma adipokines, insulin and androgens level as well as biochemical glycemic and lipidemic markers with incidence of PCOS in women with normal BMI.
Akbarzadeh S; Ghasemi S; Kalantarhormozi M; Nabipour I; Abbasi F; Aminfar A; Jaffari SM; Motamed N; Movahed A; Mirzaei M; Rahbar AR
Gynecol Endocrinol; 2012 Jul; 28(7):521-4. PubMed ID: 22309615
[TBL] [Abstract][Full Text] [Related]
23. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.
Glueck CJ; Wang P; Fontaine R; Tracy T; Sieve-Smith L
Metabolism; 1999 Apr; 48(4):511-9. PubMed ID: 10206447
[TBL] [Abstract][Full Text] [Related]
24. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
25. The Effects of Blood Glucose Regulation in Omentin-1 Levels among Diabetic Patients.
Arman Y; Kirna K; Ugurlukisi B; Kutlu O; Dikker O; Cil EO; Akarsu M; Ozcan M; Yuruyen G; Demir P; Altun O; Ozsenel EB; Erdem MG; Sandikci R; Tukek T
Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):262-266. PubMed ID: 28073124
[No Abstract] [Full Text] [Related]
26. Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?
Bongrani A; Mellouk N; Rame C; Cornuau M; Guérif F; Froment P; Dupont J
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382403
[TBL] [Abstract][Full Text] [Related]
27. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
Koivunen RM; Morin-Papunen LC; Ruokonen A; Tapanainen JS; Martikainen HK
Hum Reprod; 2001 Dec; 16(12):2546-51. PubMed ID: 11726572
[TBL] [Abstract][Full Text] [Related]
28. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
29. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
[TBL] [Abstract][Full Text] [Related]
30. Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment.
Cheng F; Zhao L; Wu Y; Huang T; Yang G; Zhang Z; Wu Y; Jia F; Wu J; Chen C; Liu D
Clin Endocrinol (Oxf); 2016 Mar; 84(3):386-93. PubMed ID: 26387747
[TBL] [Abstract][Full Text] [Related]
31. Omentin-1 levels are reduced by pharmacologic doses of leptin, but remain unaffected by energy deprivation and display no day-night variation.
Hamnvik OR; Thakkar B; Chamberland J; Aronis K; Schneider B; Mantzoros CS
Int J Obes (Lond); 2015 Feb; 39(2):260-264. PubMed ID: 24946907
[TBL] [Abstract][Full Text] [Related]
32. Serum omentin-1 levels in obese children.
Zengi S; Zengi O; Kirankaya A; Kucuk SH; Kutanis EE; Yigit O
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):247-251. PubMed ID: 30817300
[TBL] [Abstract][Full Text] [Related]
33. Can metformin reduce insulin resistance in polycystic ovary syndrome?
Açbay O; Gündoğdu S
Fertil Steril; 1996 May; 65(5):946-9. PubMed ID: 8612854
[TBL] [Abstract][Full Text] [Related]
34. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study.
Orio F; Palomba S; Cascella T; De Simone B; Manguso F; Savastano S; Russo T; Tolino A; Zullo F; Lombardi G; Azziz R; Colao A
J Clin Endocrinol Metab; 2005 Nov; 90(11):6072-6. PubMed ID: 16118336
[TBL] [Abstract][Full Text] [Related]
35. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
[TBL] [Abstract][Full Text] [Related]
36. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
[TBL] [Abstract][Full Text] [Related]
37. Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS).
Martínez-García MÁ; Montes-Nieto R; Fernández-Durán E; Insenser M; Luque-Ramírez M; Escobar-Morreale HF
J Clin Endocrinol Metab; 2013 Feb; 98(2):E388-96. PubMed ID: 23337724
[TBL] [Abstract][Full Text] [Related]
38. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
[TBL] [Abstract][Full Text] [Related]
39. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial.
Agarwal N; Rice SP; Bolusani H; Luzio SD; Dunseath G; Ludgate M; Rees DA
J Clin Endocrinol Metab; 2010 Feb; 95(2):722-30. PubMed ID: 19996308
[TBL] [Abstract][Full Text] [Related]
40. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
